Evaluation of Infusion Reactions and Infusion Times in the N-Momentum Study of Inebilizumab for NMOSD

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2021
This article has no abstract
Epistemonikos ID: 9a0f4da96158966024564d554b5af888027af6fa
First added on: Apr 30, 2026